| 1. |
- Husted, Sören, et al.
(författare)
-
Photorespiratory NH4+ Production in Leaves of Wild-Type and Glutamine Synthetase 2 Antisense Oilseed Rape
- 2002
-
Ingår i: Plant Physiology. - Rockville : American Society of Plant Biologists. - 0032-0889 .- 1532-2548. ; 130:2, s. 989-998
-
Tidskriftsartikel (refereegranskat)abstract
- Exposure of oilseed rape (Brassica napus) plants to increasing leaf temperatures between 15°C and 25°C increased photorespiratory NH4+ production from 0.7 to 3.5 µmol m-2 s-1. Despite the 5-fold increase in the rate of NH4+ production, the NH4+ concentration in root and leaf tissue water and xylem sap dropped significantly, whereas that in the leaf apoplastic fluid remained constant. The in vitro activity of glutamine synthetase (GS) in both leaves and roots also increased with temperature and in all cases substantially exceeded the observed rates of photorespiratory NH4+ production. The surplus of GS in oilseed rape plants was confirmed using GS2 antisense plants with 50% to 75% lower in vitro leaf GS activity than in the wild type. Despite the substantial reduction in GS activity, there was no tendency for antisense plants to have higher tissue NH4+ concentrations than wild-type plants and no overall correlation between GS activity and tissue NH4+ concentration was observed. Antisense plants exposed to leaf temperatures increasing from 14°C to 27°C or to a trifold increase in the O2 to CO2 ratio did not show any change in steady-state leaf tissue NH4+ concentration or in NH3 emission to the atmosphere. The antisense plants also had similar leaf tissue concentrations of glutamine, glycine, and serine as the wild type, whereas glutamate increased by 38%. It is concluded that photorespiration does not control tissue or apoplastic levels of NH4+ in oilseed rape leaves and, as a consequence, that photorespiration does not exert a direct control on leaf atmosphere NH3 fluxes.
|
|
| 2. |
- Sparber-Sauer, Monika, et al.
(författare)
-
Infantile myofibromatosis : Excellent prognosis but also rare fatal progressive disease. Treatment results of five Cooperative Weichteilsarkom Studiengruppe (CWS) trials and one registry
- 2022
-
Ingår i: Pediatric Blood & Cancer. - : John Wiley & Sons. - 1545-5009 .- 1545-5017. ; 69:3
-
Tidskriftsartikel (refereegranskat)abstract
- Background: Infantile myofibromatosis (IM) is a rare benign soft tissue tumor and often a self-limiting disease but rarely includes life-threatening complications. Little is known about optimal treatment of primary localized (LD) and multifocal disease (MFD).Methods: Treatment and outcome of 95 children with IM registered within five Cooperative Weichteilsarkom Studiengruppe (CWS) trials and one registry (1981-2016) were evaluated.Results: LD was diagnosed in 71 patients at a median age of 0.4 years (range 0.0-17.7). MFD was present in 24 patients. The mainstay of treatment was watch-and-wait strategy (w&w) after initial biopsy or resection. Low-dose chemotherapy (CHT) was administered to 16/71 (23%) patients with LD and eight of 24 (33%) patients with MFD, imatinib was added in two. A delayed resection was possible in eight of 71 (11%) and five of 24 (21%) patients with LD and MFD, respectively. Overall, patients were alive in complete remission (n = 77) and partial remission (n = 10) at a median follow-up time of 3.4 years after diagnosis (range 0.01-19.4); no data available (n = 5). Three patients died of progressive disease (PD) despite CHT. Gender, tumor size, and location correlated with a favorable event-free survival (EFS) in patients with LD. The 5-year EFS and overall survival of patients with LD were 73% (±12, confidence interval [CI] 95%) and 95% (±6, CI 95%), respectively; for MFD 51% (±22, CI 95%) and 95% (±10, CI 95%).Cconclusion: Prognosis is excellent in patients with LD and MFD. Targeted treatment needs to be evaluated for rare fatal PD.
|
|
